Millennium Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Millennium Management's ACAD Position: Q3 2026 in Review
Millennium Management increased its Acadia Pharmaceuticals (ACAD) stake by 35% in Q3 2026, buying an estimated $5.51M and bringing the position to 795,315 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #1820.
Millennium Management first reported a position in ACAD in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.5M in Q4 2016. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Millennium Management held 795,315 shares of Acadia Pharmaceuticals worth $16M as of Q3 2026.
- Millennium Management bought 205,391 Acadia Pharmaceuticals shares in Q3 2026, an estimated $5.51M.
- Acadia Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1820 holding.
- Millennium Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Acadia Pharmaceuticals position peaked at $55.5M in Q4 2016.
- 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.